Device for Fluid Output

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Duke University, Durham, NC
Fluid Output
Electronic Device for Toilet - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

The purpose of this study is to determine whether a prototype toilet device that we have developed can accurately and automatically track human fluid output from renal and gastrointestinal systems in the hospital. The device includes components that can be outfitted onto existing toilets. In this study, participants hospital room will be outfitted with the prototype toilet device. Participants will use the toilet as usual throughout the duration of their inpatient stay. Sometimes output will be measured by the device, and other times output will be measured manually by nurses.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 10 Secondary · Reporting Duration: After transition to Stage 2 - about 3 days after patient begins HCT conditioning

Day 3
Percent of nurses who indicated device satisfaction as measured by nurse survey
Percent of nurses who perceived lower chemotherapy exposure as measured by survey
Day 3
Percent of patients who indicated device satisfaction as measured by patient survey
Day 3
Levels of chemotherapy drugs detectable on room surfaces as measured by surface testing
Time (in mins) spent handling/recording patient waste
Up to 14 days
Correlation between daily patient fluid balance (difference between fluid input and output in mL) as measured by device measurements or standard of care nurse assessment and the change in daily weight
Mean absolute error of urine volume (in mL) as measured by device
Mean absolute error of urine volume (in mL) as measured by device compared to standard of care nurse assessment
Percent device can correctly identify diarrhea events
Time (in mins) between nurse logging of patient urination in electronic medical records and device-based logging of patient urination
Up to 17 days
Number of patient falls as measured by patient report

Trial Safety

Trial Design

2 Treatment Groups

Control
1 of 2
Device
1 of 2
Active Control
Experimental Treatment

54 Total Participants · 2 Treatment Groups

Primary Treatment: Device · No Placebo Group · N/A

Device
Device
Experimental Group · 1 Intervention: Electronic Device for Toilet · Intervention Types: Device
ControlNoIntervention Group · 1 Intervention: Control · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: after transition to stage 2 - about 3 days after patient begins hct conditioning
Closest Location: Duke University · Durham, NC
Photo of Duke University Medical Center  1Photo of nc duke university  2Photo of nc duke university  3
2004First Recorded Clinical Trial
1 TrialsResearching Fluid Output
523 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are able to read and write English.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.